% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@MISC{Hampton:282919,
      author       = {Hampton Leonard and Mike Nalls and Dan Vitale and Mathew
                      Koretsky and Kristin Levine and Mary Makarious and Fang,
                      Zih-Hua and Jones, Lietsel and Solle, J.},
      title        = {{D}ataset: {G}lobal {P}arkinson's {G}enetics {P}rogram
                      {D}ata {R}elease 10, v5},
      publisher    = {Zenodo},
      reportid     = {DZNE-2025-01380},
      year         = {2025},
      abstract     = {In July 2025, GP2 announced the 10th data release on the
                      Terra and the Verily® Workbench platforms in collaboration
                      with AMP® PD. This release includes 11,109 additional
                      genotyped participants and 13,339 additional WGS
                      participants. The genotype array (NBA) data, including
                      locally-restricted samples, now consists of a total of
                      82,944 genotyped participants (36,939 PD cases, 19,821
                      Controls, and 26,184 ‘Other’ phenotypes). When removing
                      the locally-restricted samples, these now consist of 65,303
                      samples (28,586 PD cases, 15,258 Controls, and 21,459
                      ‘Other’ phenotypes). The whole genome sequencing (WGS)
                      data now consists of a total of 21,073 sequenced
                      participants (8,134 PD cases, 3,531 Controls, and 9,408
                      ‘Other’ phenotypes). When removing the
                      locally-restricted samples, these now consist of 16,608
                      participants (6,801 PD cases, 3,244 Controls, and 6,563
                      ‘Other’ phenotypes). Of note, cases recruited via the
                      Monogenic network are coded as ‘Other’. The clinical
                      exome data now consists of 10,454 samples with PD (Release
                      8). Of the 92,021 unique samples with genetic data (NBA,
                      WGS, or clinical exome), 26,982 individuals also have
                      additional extended clinical information. Please see the
                      accompanying blog for further description of this release.
                      To obtain data access, please see
                      https://amp-pd.org/researchers/data-use-agreement. For any
                      publications using data from this release, please reference
                      the DOI number and the following statement: 'Data (DOI
                      10.5281/zenodo.15748014, release 10) and/or code used in the
                      preparation of this article were obtained from Global
                      Parkinson’s Genetics Program (GP2). GP2 is funded by the
                      Aligning Science Across Parkinson’s (ASAP) initiative and
                      implemented by The Michael J. Fox Foundation for
                      Parkinson’s Research (https://gp2.org). For a complete
                      list of GP2 members see https://gp2.org.'},
      cin          = {AG Heutink},
      cid          = {I:(DE-2719)1210002},
      pnm          = {354 - Disease Prevention and Healthy Aging (POF4-354)},
      pid          = {G:(DE-HGF)POF4-354},
      typ          = {PUB:(DE-HGF)32},
      doi          = {10.5281/zenodo.15748014},
      url          = {https://pub.dzne.de/record/282919},
}